Drontal pup 5 mg/ml - 15 mg/ml Suspensie voor oraal gebruik
Drontal pup 5 mg/ml - 15 mg/ml Suspensie voor oraal gebruik
Authorised
- Febantel
- Pyrantel
Product identification
Medicine name:
Drontal pup 5 mg/ml - 15 mg/ml Suspensie voor oraal gebruik
Active substance:
- Febantel
- Pyrantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Febantel15.00/milligram(s)1.00millilitre(s)
-
Pyrantel5.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Drontal pup 100 ml Vial Oral suspension
- Drontal pup 50 ml Vial Oral suspension
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V192281
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
